NCT05571189 is a NA clinical trial of Daily Activity Text in Pulmonary Embolism, sponsored by University of Rochester.

Who is sponsoring NCT05571189?

NCT05571189 is sponsored by University of Rochester.

What drugs are being tested in NCT05571189?

Interventions in NCT05571189: Daily Activity Text, Control Text.

What condition does NCT05571189 study?

NCT05571189 studies Pulmonary Embolism.

Is NCT05571189 still recruiting?

NCT05571189 is currently completed. Last updated 2 October 2025.

Last reviewed 2025-10-02 · How we verify

NCT05571189

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Home Rehabilitation After Acute Pulmonary Embolism

Completed NA Last updated 2 October 2025

What this trial tests

NA trial testing Daily Activity Text in Pulmonary Embolism in 32 participants. Completed in 24 September 2025.

Timeline

19 December 2022

Primary endpoint
24 September 2025

24 September 2025

Quick facts

Lead sponsor	University of Rochester
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	32
Start date	19 December 2022
Primary completion	24 September 2025
Estimated completion	24 September 2025
Sites	1 location across United States

Drugs / interventions tested

Daily Activity Text
Control Text

Conditions studied

Pulmonary Embolism — all drugs for Pulmonary Embolism →

Sponsor

University of Rochester

Who can join

18 and older, any sex, with Pulmonary Embolism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate whether a home rehabilitation program after hospitalization for acute pulmonary embolism (PE) improves clinical outcomes at 3 months compared to usual care. Daily physical activity tasks that incorporate heart rate monitoring will be sent through email or text. This information could help improve the management of acute PE.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Electronically delivered rehabilitation after acute pulmonary embolism is safe and improves quality of life.
Lachant D, Haight D, Roto D, Williams A, et al · · 2024 · cited 6× · PMID 38754964 · DOI 10.1183/13993003.00175-2024

Verify or expand the search:

Other recruiting trials for Pulmonary Embolism

Currently open trials in the same condition.

NCT07381712 — High-Flow Nasal Cannula Versus Non-Invasive Ventilation for Acute Respiratory Failure in Pulmonary Embolism. · NA · active not recruiting
NCT04211181 — CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism · NA · recruiting
NCT07003646 — Reperfusion Treatment in Acute Pulmonary Embolism · recruiting
NCT06600542 — Inari VISION Registry · recruiting
NCT06622876 — Incidental Discovery of Pulmonary Emboli Via CT Scan: Impact of Detections on Patient Care and Resulting Complications · recruiting

Other University of Rochester trials

Trials by the same sponsor.

NCT07075965 — Calcium Channel Blocker in Myotonic Dystrophy Type 1 · Phase 1 · not yet recruiting
NCT07423104 — A Study of Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory or Secondary Acute Myeloi · Phase 2 · not yet recruiting
NCT05744869 — SBAT for Health Equity · NA · not yet recruiting
NCT06052956 — Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses · Phase 2 · not yet recruiting
NCT07032636 — Reducing Crises and Suicide Within the Idaho Army National Guard · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05571189 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Rochester
Last refreshed: 2 October 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05571189.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing